The All New Synthetic


Randy Rettberg is building an industry -- or at least he's trying. While interest in synthetic biology continues to grow by leaps and bounds, its use in real-world science has remained fairly minimal. Synthetic biology, or the goal of developing an engineering discipline that can build biological systems in the way that other engineers can build chemical or computational systems, is still young. "I think that the field is very, very early," says Rettberg at MIT. While it's 2007 for the rest of us, "in many ways it's much more like 1850 in this corner of the world.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.